Skip to main content
. 2020 Apr 27;12(5):1089. doi: 10.3390/cancers12051089

Figure 3.

Figure 3

Anti-VEGF antibody reprograms the tumor microenvironment from immune suppressive to immune permissive (modified from ref. [4] with permission).